Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Ruixi Biological Technology is a specialized biotechnology company focused on the development and manufacture of advanced chemical reagents and nanomaterials for life science research. The company's core product portfolio includes functionalized polyethylene glycol (PEG) derivatives, high-purity phospholipids, fluorescent dyes, and a variety of metal and magnetic nanoparticles. Xi'an Ruixi also provides extensive custom synthesis services, supporting researchers in drug delivery, molecular imaging, and diagnostic development. By offering specialized materials like click chemistry reagents and PROTAC linkers, the company enables complex bioconjugation and formulation studies. Their services cater to a global clientele across academic institutions and the pharmaceutical industry. The company is recognized for its expertise in surface modification and the production of biocompatible materials used in cutting-edge biomedical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xian Ruixi.